Request Pricing

Global Infectious Disease Situation Update

Reporting Period: June 1-7, 2026

The AeroClenz Chief Medical Officer periodically reviews publicly available infectious disease surveillance reports from organizations such as the Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), and European Centre for Disease Prevention and Control (ECDC).

These summaries are intended to provide general awareness of global infectious disease activity relevant to international travel, healthcare systems, and high-traffic indoor environments.

This information is provided for situational awareness only and does not constitute medical advice.

Key Takeaways

For the period of June 1–7, 2026, several notable global infectious disease developments were observed:

  • Ebola virus disease activity in the Democratic Republic of the Congo and Uganda remains the most significant ongoing outbreak under international surveillance
  •  Measles continues to generate outbreaks globally and remains a highly disruptive communicable disease due to its transmissibility
  • Mpox transmission continues in multiple African countries and remains an active area of international monitoring
  • Respiratory disease surveillance remains focused on MERS-CoV, influenza, SARS-CoV-2 variants, and other emerging pathogens
  • Seasonal mosquito-borne diseases are expected to increase across the Northern Hemisphere during the summer months

Top 5 Signals

1) Ebola Outbreak Activity in Central Africa

Ebola virus disease remains the most significant infectious disease event currently under international surveillance.

Recent reporting indicates continued transmission in eastern Democratic Republic of the Congo, with cross-border activity involving Uganda. Public-health agencies continue to monitor healthcare-associated transmission, regional spread, and response efforts in affected areas.

Current assessments from WHO, CDC, and ECDC continue to characterize the broader global risk as low while recognizing the substantial impact within affected regions.

2) Measles Continues to Drive Outbreak Activity

Measles remains one of the most consequential infectious diseases globally due to its combination of high transmissibility and international travel-associated spread.

Ongoing outbreaks in multiple countries remain linked to immunity gaps and imported cases. Public health agencies emphasize that measles can lead to extensive contact investigations and resource-intensive response efforts following a single exposure.

3) Mpox Remains Under Active Surveillance

Mpox activity continues in several African countries, with ongoing monitoring by international health organizations.

While current global risk assessments remain lower than those associated with Ebola or widespread measles outbreaks, mpox remains relevant due to continued transmission, travel-associated exposures, and evolving epidemiological patterns.

4) Respiratory Disease Surveillance Continues

Global respiratory disease activity remains relatively stable.

International surveillance programs continue monitoring:

  • MERS-CoV
  • SARS-CoV-2 variants
  • Seasonal influenza
  • Other emerging respiratory pathogens

No major respiratory disease escalation was identified during this reporting period, though ongoing surveillance remains important.

5) Vector-Borne Diseases Enter Seasonal Peak

As summer approaches in the Northern Hemisphere, mosquito-borne diseases are expected to become increasingly relevant.

Public-health agencies continue monitoring:

  • West Nile virus
  • Malaria
  • Dengue
  • Chikungunya
  • Other arboviral diseases

Travel-related exposure risks may increase during the coming months, particularly in endemic regions.

Global Situation Overview

Ebola Virus Disease

The current Ebola outbreak involving Bundibugyo virus disease remains the most significant infectious disease event during this reporting period.

Key factors being monitored include:

  • Continued transmission in eastern Democratic Republic of the Congo
  • Cross-border activity involving Uganda
  • Healthcare-associated infections
  • Operational challenges affecting outbreak response

While regional impacts remain significant, international public-health agencies continue to assess the risk of broader global spread as low.

Measles

Measles continues to be a major public-health concern worldwide.

Ongoing outbreaks are being driven by:

  • Immunity gaps in susceptible populations
  • International travel-associated introductions
  • High transmissibility in congregate environments

The disease remains notable for its ability to generate extensive public health response efforts following individual cases.

Mpox

Mpox transmission remains active in multiple regions, particularly in parts of Africa.

International surveillance continues to focus on transmission patterns, case trends, and potential travel-related implications.

Respiratory Diseases

Global respiratory disease activity remains relatively stable.

Current monitoring efforts continue to focus on:

  • MERS-CoV
  • Influenza viruses
  • SARS-CoV-2 variants
  • Emerging respiratory threats

No major changes in global respiratory risk were reported during this period.

Vector-Borne Diseases

Seasonal increases in mosquito activity are expected to elevate exposure risk for several vector-borne diseases.

Travelers and public-health agencies continue to monitor diseases such as malaria, dengue, chikungunya, and West Nile virus as summer progresses.

Summary

The global infectious disease landscape for early June 2026 is characterized by ongoing outbreak activity in specific regions alongside stable respiratory disease surveillance and increasing seasonal vector-borne disease concerns.

Key themes include:

  • Continued Ebola outbreak activity in Central Africa
  • Ongoing global measles outbreaks and travel-associated transmission risks
  • Active mpox surveillance in multiple countries
  • Stable respiratory disease conditions with continued monitoring
  • Increasing relevance of mosquito-borne diseases during the Northern Hemisphere summer season

Public-health surveillance agencies continue to monitor these developments and publish updates as new information becomes available.

Sources referenced in this summary include the Centers for Disease Control and Prevention (CDC), the World Health Organization (WHO), the European Centre for Disease Prevention and Control (ECDC), and other publicly available international surveillance reports.

To learn more about AeroClenz, visit www.aeroclenz.com. Follow AeroClenz on social media for updates on research and technology developments.

LinkedIn: https://www.linkedin.com/company/aeroclenz
Facebook: https://www.facebook.com/AeroClenz
Instagram: https://www.instagram.com/aeroclenz_

Get Updates Automatically
Translate »
Scroll to Top

Michael Stroup

Chief Operations Officer

Michael is a results-driven leader with 20 years of experience improving operations to achieve greater organizational effectiveness, productivity, and performance across multiple industries. Most recently Michael served as Integration Engineering Manager at CooperSurgical, a leading fertility medical device manufacturer. Prior to CSI, he has a proven track record of driving operational and engineering excellence within medical device, food, electronics and automotive industries by leading day to day operations and providing effective strategic leadership/execution.  His expertise includes, but is not limited to, global production set up, process improvements, machinery design and compliance. Michaels holds a Bachelor of Science in Mechanical Engineering Technology and Industrial Automotive Technology from Indiana State University and a Master of Science in Industrial Technology from Indiana State University.

Matt Saberton

CEO, Founder, Co-Inventor

Matt has been passionate about aviation from a young age, earning his private pilot’s license in high school. After obtaining a degree in Aviation and Aerospace Science, he began his career as a flight instructor and then became an air ambulance pilot, where he recognized the importance of cabin cleanliness.

Rising through the ranks at one of the largest worldwide charter airlines, Matt became Captain and later Chief Pilot, gaining deep insights into maintaining safe environments in aviation. This experience led him to found Aeroclenz, Inc., where he now serves as CEO.

Under his leadership, Aeroclenz has transitioned from an aerospace-focused company to a leader in UV disinfection solutions, offering custom products for both aerospace and terrestrial indoor applications. While the company’s roots are in aviation, its technologies now ensure high standards of cleanliness across various industries.

Jameson Trettenero

Director of Marketing

Jameson is a seasoned marketing expert with experience driving strategic marketing initiatives across a diverse array of industries. In his role, Jameson leads the marketing efforts with a focus on innovative growth strategies, brand elevation, and data-driven decision-making that align with the company’s overarching business goals.

Before joining Aeroclenz, Jameson held key leadership positions at top-tier digital agencies. In his agency experience, he spearheaded multi-divisional teams across disciplines including SEO, Paid Media, Analytics, and Creative. His strategic oversight and client-centric approach significantly enhanced client retention and business growth, particularly across enterprise-level accounts.

Jameson’s expertise extends to managing complex client relationships, advising C-level executives, and navigating the intricacies of the marketing landscape. His ability to harmonize creativity with analytics has consistently driven measurable success for clients, from Fortune 500 companies to emerging brands.